Who owns Scribe Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SCTX from SEC Form 13F filings across 63 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 63 institutions disclosed 16.2M shares of Scribe Therapeutics, Inc. worth $297.1M — about 111.7% of shares outstanding; the largest disclosed holder is a16z Capital Management, L.L.C.. Source: SEC Form 13F filings, parsed by EvidInvest.
63
13F holders
$297.1M
value, 2026 filers
111.7%
of shares outstanding (16.2M sh)
63
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SCTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | a16z Capital Management, L.L.C.NEW | 3.1M | $56.7M | 0.3% | 21.3% | new |
| 2 | Avoro Capital Advisors LLCNEW | 2.6M | $47.8M | 0.5% | 17.9% | new |
| 3 | RA CAPITAL MANAGEMENT, L.P.NEW | 1.8M | $33.2M | 0.3% | 12.4% | new |
| 4 | ORBIMED ADVISORS LLCNEW | 1.3M | $24.8M | 0.5% | 9.3% | new |
| 5 | PERCEPTIVE ADVISORS LLCNEW | 920,341 | $16.9M | 0.3% | 6.3% | new |
| 6 | ARK Investment Management LLCNEW | 786,921 | $14.5M | 0.1% | 5.4% | new |
| 7 | BAKER BROS. ADVISORS LPNEW | 688,691 | $12.7M | 0.1% | 4.8% | new |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 684,706 | $12.6M | 0.0% | 4.7% | new |
| 9 | BlackRock, Inc.NEW | 679,786 | $12.5M | 0.0% | 4.7% | new |
| 10 | SanofiNEW | 500,000 | $9.2M | 1.5% | 3.4% | new |
| 11 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 407,630 | $7.5M | 0.0% | 2.8% | new |
| 12 | FRANKLIN TEMPLETON INCNEW | 380,019 | $6.4M | 0.0% | 2.6% | new |
| 13 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 380,000 | $7.0M | 0.0% | 2.6% | new |
| 14 | FARALLON CAPITAL MANAGEMENT, L.L.C.NEW | 380,000 | $7.0M | 0.0% | 2.6% | new |
| 15 | GEODE CAPITAL MANAGEMENT, LLCNEW | 245,412 | $4.5M | 0.0% | 1.7% | new |
| 16 | STATE STREET CORPNEW | 171,147 | $3.1M | 0.0% | 1.2% | new |
| 17 | Alyeska Investment Group, L.P.NEW | 150,000 | $2.8M | 0.0% | 1% | new |
| 18 | Menlo Ventures Management, L.P.NEW | 97,690 | $1.8M | 0.7% | 0.7% | new |
| 19 | TD ASSET MANAGEMENT INCNEW | 83,342 | $1.9M | 0.0% | 0.6% | new |
| 20 | Sumitomo Mitsui Trust Group, Inc.NEW | 74,910 | $1.4M | 0.0% | 0.5% | new |
| 21 | Amova Asset Management Americas, Inc.NEW | 74,910 | $1.4M | 0.0% | 0.5% | new |
| 22 | NORTHERN TRUST CORPNEW | 74,721 | $1.4M | 0.0% | 0.5% | new |
| 23 | UBS Group AGNEW | 71,067 | $1.3M | 0.0% | 0.5% | new |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 67,039 | $1.2M | 0.0% | 0.5% | new |
| 25 | VANGUARD FIDUCIARY TRUST CONEW | 64,267 | $1.2M | 0.0% | 0.4% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.